| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/02/2000 | CA2339968A1 Dcr5, a bmp-binding protein, and applications thereof |
| 03/02/2000 | CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
| 03/02/2000 | CA2339860A1 Human cell signaling proteins (csig) |
| 03/02/2000 | CA2335379A1 Genetic method for the expression of polyproteins in plants |
| 03/01/2000 | EP0982405A2 Recombinant alphavirus vectors |
| 03/01/2000 | EP0982400A1 Human glycine transporter |
| 03/01/2000 | EP0982318A2 Enchanced phosphorylation of P53 by ATM in response to DNA damage |
| 03/01/2000 | EP0981635A1 Production of mature proteins in plants |
| 03/01/2000 | EP0981631A1 Polypeptides having aminopeptidase activity and nucleic acids encoding same |
| 03/01/2000 | EP0981630A1 Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same |
| 03/01/2000 | EP0981629A1 Forms of prostate specific antigen and methods for their detection |
| 03/01/2000 | EP0981627A1 Purified telomerase |
| 03/01/2000 | EP0981625A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES |
| 03/01/2000 | EP0981620A1 Hgf polypeptides and their use in therapy |
| 03/01/2000 | EP0981618A1 Apo-2 RECEPTOR |
| 03/01/2000 | EP0981606A2 Method and construct for inhibition of cell migration |
| 03/01/2000 | EP0981599A2 Method for increasing yields or recombinant proteins |
| 03/01/2000 | EP0981550A1 Methods for eosinophil depletion and compositions therefor |
| 03/01/2000 | EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
| 03/01/2000 | EP0981547A1 Tumor-associated antigen |
| 03/01/2000 | EP0981541A1 Psca: prostate stem cell antigen |
| 03/01/2000 | EP0769020B1 NEW hIL-4 MUTANT PROTEINS USED AS ANTAGONISTS OR PARTIAL AGONISTS OF HUMAN INTERLEUKIN 4 |
| 03/01/2000 | CN1245721A Method for preparing intestinal transmitted non-A and non-B hepatitis vaccine |
| 03/01/2000 | CN1245719A Antithrombosis medicine using inactive insuline as skeleton and containing arginine-glycine-aspartic acid sequence |
| 02/29/2000 | US6031150 Genome with homozygous disruption of gene by selectable marker; for studying non-insulin dependent diabetes mellitus and persistent hyperinsulinemic hypoglycemia of infancy |
| 02/29/2000 | US6031090 Molecular cloning of a 7TM receptor (GPR31A) |
| 02/29/2000 | US6031087 Nucleotide sequences or complementary sequences of a type ii serine protease inhibitor precursor from a plant; for pathogen resistant transgenic plants |
| 02/29/2000 | US6031079 Amino acid sequence; for screening modulators |
| 02/29/2000 | US6030945 Apo-2 ligand |
| 02/29/2000 | US6030944 Cyclohexapeptidyl bisamine compounds |
| 02/29/2000 | US6030835 Methods and composition for identifying group a streptococcus |
| 02/29/2000 | US6030831 Tie ligand homologues |
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030812 Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors |
| 02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
| 02/29/2000 | US6030808 Nucleic acids encoding receptor recognition factor stat 3 and methods of use thereof |
| 02/29/2000 | US6030796 Complementary dna sequence which codes for a chimeric antibody directed to an extracellular epitope of the human trans-plasma membrane p-glycoprotein to strongly suppress drug efflux and increase cytotoxicity of anticancer agents |
| 02/29/2000 | US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy |
| 02/29/2000 | US6030784 Method for simultaneous identification of differentially expressed mRNAS and measurement of relative concentrations |
| 02/29/2000 | US6030772 Neutralizing antibodies against HIV infection |
| 02/29/2000 | US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | CA2182207C Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
| 02/29/2000 | CA2077753C Purified gp120 composition retaining natural conformation |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/28/2000 | CA2249037A1 Novel compounds |
| 02/26/2000 | CA2280675A1 Enhanced phosphorylation of p53 by atm in response to dna damage |
| 02/24/2000 | WO2000009755A2 Domain specific gene evolution |
| 02/24/2000 | WO2000009739A1 Monoclonal antibody against canine trypsin |
| 02/24/2000 | WO2000009735A1 A cyclic lipopeptide from cryptosporiopsis quercina possessing antifungal activity |
| 02/24/2000 | WO2000009716A1 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/24/2000 | WO2000009715A1 Modulation of polypeptide display on modified filamentous phage |
| 02/24/2000 | WO2000009714A1 Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression |
| 02/24/2000 | WO2000009712A1 Transcription factors regulating the expression of ethylene-inducible genes |
| 02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 02/24/2000 | WO2000009709A2 Proteases and associated proteins |
| 02/24/2000 | WO2000009695A2 Drug targets in candida albicans |
| 02/24/2000 | WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009689A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
| 02/24/2000 | WO2000009688A1 Novel gene and protein osbh encoded thereby |
| 02/24/2000 | WO2000009687A1 Novel gene and protein gmp30 encoded thereby |
| 02/24/2000 | WO2000009686A1 Gene |
| 02/24/2000 | WO2000009671A1 Process for purifying human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009560A2 Generation of modified molecules with increased serum half-lives |
| 02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009551A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009550A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | WO2000009543A2 Hepatitis c inhibitor tri-peptides |
| 02/24/2000 | WO2000009541A1 nrdE |
| 02/24/2000 | WO2000009538A2 Canine growth hormone secretagogue receptor |
| 02/24/2000 | WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | WO2000009464A1 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 02/24/2000 | WO2000009154A1 Bacterial superantigen vaccines |
| 02/24/2000 | WO2000009018A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 02/24/2000 | WO1999065947A3 Monoclonal antibodies directed against the g3bp protein, and uses |
| 02/24/2000 | WO1999058692A3 Human apoptosis associated proteins |
| 02/24/2000 | WO1999058684A3 Compounds from moraxella catarrhalis |
| 02/24/2000 | WO1999053046A3 Noncloning technique for expressing a gene of interest |
| 02/24/2000 | WO1999042586A3 Exo1 and exo2, exocytotic proteins |
| 02/24/2000 | DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis |
| 02/24/2000 | CA2341029A1 Generation of modified molecules with increased serum half-lives |
| 02/24/2000 | CA2340428A1 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
| 02/24/2000 | CA2340095A1 Canine growth hormone secretagogue receptor |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339575A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 02/24/2000 | CA2339518A1 Gene |
| 02/24/2000 | CA2339420A1 Domain specific gene evolution |
| 02/24/2000 | CA2339418A1 Human chordin-related proteins and polynucleotides encoding them |
| 02/24/2000 | CA2339409A1 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339338A1 Vanadate resistance glycosylation 4 gene |
| 02/24/2000 | CA2339337A1 Drug targets in candida albicans |
| 02/24/2000 | CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | CA2339048A1 Monoclonal antibody against canine trypsin |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |